Clostridium difficile infection trials: what is the primary endpoint?

Details

Request a copyRequest a copy
Serval ID
serval:BIB_21E6A02CC97F
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
UNIL/CHUV
Title
Clostridium difficile infection trials: what is the primary endpoint?
Journal
The Lancet. Infectious diseases
Author(s)
Guery B.
ISSN
1474-4457 (Electronic)
ISSN-L
1473-3099
Publication state
Published
Issued date
03/2019
Peer-reviewed
Oui
Volume
19
Number
3
Pages
219-220
Language
english
Notes
Publication types: Journal Article ; Comment
Publication Status: ppublish
Keywords
Clostridioides difficile, Clostridium Infections, Double-Blind Method, Enterocolitis, Pseudomembranous, Humans, Oxazolidinones
OAI-PMH
oai:serval.unil.ch:BIB_21E6A02CC97F
DOI
10.1016/S1473-3099(18)30626-1
Pubmed
30709664
Web of science
000459919500009
Create date
17/03/2019 17:13
Last modification date
18/07/2023 6:56
Usage data